Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CYB pseudogene 8 (MTCYBP8) is a human pseudogene and not a protein-coding gene or functional therapeutic target[4]. It is related to the mitochondrial cytochrome b gene (MT-CYB), which encodes a core component of the mitochondrial electron transport chain’s complex III, but MTCYBP8 itself does not produce the cytochrome b protein and, as a pseudogene, does not have known biological function, therapeutic relevance, or disease association in current literature[4]. References concerning the functional MT-CYB gene (not the pseudogene MTCYBP8) indicate roles in mitochondrial energy production, involvement in mitochondrial complex III deficiency, and links to metabolic disorders and mitochondrial disease[1][3][5]. However, the pseudogene MTCYBP8 is not recognized as a receptor, enzyme, transporter, transcription factor, or any other molecular class relevant for therapeutic targeting—it is a non-coding genomic element. As such, there are no known biomarker, disease, drug, safety, or therapeutic-related attributes for MTCYBP8. The query appears to confuse the functional cytochrome b gene (MT-CYB), which codes for an essential mitochondrial respiratory chain protein, with its pseudogene MTCYBP8[4]. Only the *functional* MT-CYB gene/protein is considered a therapeutic target or relevant for disease and drug interaction studies. MTCYBP8 should be marked as **not a therapeutic target** and the entry is **incorrect for purposes of drug discovery, disease association, or biological function**[4]. If structured biomedical information is needed, focus should be shifted to the *functional* MT-CYB gene, not MTCYBP8.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CYB pseudogene 8 (MTCYBP8).